See also this year's filing and all EDGAR filings for this company.
PDF Report 0001335105_2015_Lixte_Biotechnology_Holdings_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| warning | Expenses in unusual place in relation to revenue | input.sec.calculation_linkbase.edgar_model_mapping | {'expenses_node': 'OperatingExpenses', 'revenue_node': 'Revenues', 'net_inc_node': 'NetIncomeLoss'} |
Graph
Absolute values for 0001335105, Lixte Biotechnology Holdings INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 539,299 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 273,437 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,285,173 |
| 9 | ResearchAndDevelopmentExpense | 1,117,970 |
| 10 | remainder_Expenses | 363,111 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 66.0 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 539,299 |
| 1 | Liabilities | 273,437 |
| 2 | Expenses | 2,766,254 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 265,862 |
| 5 | NetIncome | -2,766,188 |
| 6 | ComprehensiveNetIncome | -2,766,188 |
| 7 | BaseVar | 1,789,528 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -5.38 |
| 9 | EconomicCapitalRatio | 0.139 |
Edgar->Model Mapping
Feature Distribution
Change over Time
